Envista Holdings Corp. (NVST)
27.28
-0.31
(-1.12%)
USD |
NYSE |
Sep 04, 16:00
27.28
0.00 (0.00%)
After-Hours: 20:00
Envista Holdings Research and Development Expense (Quarterly) : 30.40M for June 30, 2026
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 30.40M |
| March 31, 2026 | 30.00M |
| December 31, 2025 | 32.10M |
| September 30, 2025 | 28.30M |
| June 30, 2025 | 28.30M |
| March 31, 2025 | 25.30M |
| December 31, 2024 | 26.70M |
| September 30, 2024 | 25.50M |
| June 30, 2024 | 23.60M |
| March 31, 2024 | 23.30M |
| December 31, 2023 | 20.20M |
| September 30, 2023 | 22.30M |
| June 30, 2023 | 26.80M |
| March 31, 2023 | 24.50M |
| December 31, 2022 | 24.60M |
| September 30, 2022 | 26.00M |
| June 30, 2022 | 25.10M |
| Date | Value |
|---|---|
| March 31, 2022 | 24.40M |
| December 31, 2021 | 24.80M |
| September 30, 2021 | 24.00M |
| June 30, 2021 | 25.90M |
| March 31, 2021 | 25.80M |
| December 31, 2020 | 23.20M |
| September 30, 2020 | 20.00M |
| June 30, 2020 | 16.50M |
| March 31, 2020 | 34.70M |
| December 31, 2019 | 35.40M |
| September 30, 2019 | 36.30M |
| June 30, 2019 | 39.70M |
| March 31, 2019 | 43.30M |
| December 31, 2018 | 43.60M |
| September 30, 2018 | 42.30M |
| June 30, 2018 | 44.40M |
| March 31, 2018 | 41.70M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Align Technology, Inc. | 102.03M |
| Dentsply Sirona, Inc. | 45.00M |
| Globus Medical, Inc. | 36.32M |
| Teleflex, Inc. | 45.12M |
| Milestone Scientific, Inc. | 0.0066M |